The mast cell and theophylline in asthma

Area of Science:

• Immunology
• Pharmacology
• Respiratory Medicine

Background:

• Mast cells play a critical role in bronchial inflammation and hyperreactivity, key features of asthma.
• Inflammation results from mast cell mediators, including vasoactive substances, chemotactic factors, and enzymes.
• Adenosine, a mast cell mediator derived from adenosine triphosphate, contributes to bronchospasm and augments mediator release.

Purpose of the Study:

• To investigate the role of adenosine as a mast cell-derived inflammatory mediator in asthma.
• To evaluate the potential of theophylline to inhibit the pro-asthmatic effects of adenosine.

Main Methods:

• The study focuses on the mechanism of adenosine's action as a mast cell mediator.
• Investigated the effect of theophylline on adenosine-induced bronchospasm and mediator release.
• Assessed theophylline's efficacy at concentrations not affecting cyclic adenosine monophosphate metabolism.

Main Results:

• Adenosine acts as a significant inflammatory mediator, causing bronchospasm and enhancing mast cell mediator release via receptor interaction.
• Theophylline effectively inhibits the pro-asthmatic actions of adenosine at achievable human concentrations.
• Inhibition occurs at theophylline concentrations insufficient to alter cyclic adenosine monophosphate metabolism.

Conclusions:

• Adenosine is a key mediator in mast cell-driven bronchial inflammation and asthma.
• Theophylline's ability to inhibit adenosine binding to mast cell receptors offers a new therapeutic strategy for asthma.
• Xanthine drugs, like theophylline, may be valuable for asthma treatment by targeting adenosine's effects.